Uncategorized
Pixium Vision receives FDA approval to begin human clinical study of its PRIMA sub-retinal implant in the US
PARIS--(BUSINESS WIRE)--Regulatory News: Pixium Vision (Paris:PIX) (FR0011950641 - PIX), a company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, announced today that it has received the approval from the US Food and Drug Administration (FDA) to begin the clinical feasibility study for PRIMA, Pixium Vision’s new-generation miniaturized wireless photovoltaic sub-retinal implant, in patients with Atrophic Dry Age-related Ma